Literature DB >> 29426658

Vaccination in immunocompromised host: Recommendations of Italian Primary Immunodeficiency Network Centers (IPINET).

Baldassarre Martire1, Chiara Azzari2, Raffaele Badolato3, Clementina Canessa2, Emilia Cirillo4, Vera Gallo4, Simona Graziani5, Tiziana Lorenzini3, Cinzia Milito6, Raffaella Panza7, Viviana Moschese5.   

Abstract

Infectious complications are a major cause of morbidity and mortality in patients with primary or secondary immunodeficiency. Prevention of infectious diseases by vaccines is among the most effective healthcare measures mainly for these subjects. However immunocompromised people vary in their degree of immunosuppression and susceptibility to infection and, therefore, represent a heterogeneous population with regard to immunization. To date there is no well- established evidence for use of vaccines in immunodeficient patients, and indications are not clearly defined even in high-quality reviews and in most of the guidelines prepared to provide recommendations for the active vaccination of immunocompromised hosts. The aim of this document is to issue recommendations based on published literature and the collective experience of the Italian primary immunodeficiency centers, about how and when vaccines can be used in immunocompromised patients, in order to facilitate physician decisions and to ensure the best immune protection with the lowest risk to the health of the patient.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Primary immunodeficiency; Secondary immunodeficiency; Syndromic immunodeficiency; Vaccination

Mesh:

Substances:

Year:  2018        PMID: 29426658     DOI: 10.1016/j.vaccine.2018.01.061

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  8 in total

Review 1.  Immunizing the imperfect immune system: Coronavirus disease 2019 vaccination in patients with inborn errors of immunity.

Authors:  Jessica R Durkee-Shock; Michael D Keller
Journal:  Ann Allergy Asthma Immunol       Date:  2022-06-16       Impact factor: 6.248

Review 2.  Vaccination of immune compromised children-an overview for physicians.

Authors:  Laure F Pittet; Klara M Posfay-Barbe
Journal:  Eur J Pediatr       Date:  2021-03-05       Impact factor: 3.183

Review 3.  Vaccination in Multiple Sclerosis: Friend or Foe?

Authors:  Tobias Zrzavy; Herwig Kollaritsch; Paulus S Rommer; Nina Boxberger; Micha Loebermann; Isabella Wimmer; Alexander Winkelmann; Uwe K Zettl
Journal:  Front Immunol       Date:  2019-08-07       Impact factor: 7.561

4.  One step closer to influenza vaccine inclusiveness.

Authors:  Mayla Sgrulletti; Giorgio Ottaviano; Maria Sangerardi; Loredana Chini; Rosa Maria Dellepiane; Baldassarre Martire; Davide Montin; Caterina Rizzo; Viviana Moschese
Journal:  Pediatr Allergy Immunol       Date:  2020-11       Impact factor: 6.377

Review 5.  A Review of Vaccinations in Adult Patients with Secondary Immunodeficiency.

Authors:  Elda Righi; Tolinda Gallo; Anna Maria Azzini; Fulvia Mazzaferri; Maddalena Cordioli; Mara Merighi; Evelina Tacconelli
Journal:  Infect Dis Ther       Date:  2021-03-09

Review 6.  Vaccination in PADs.

Authors:  Cinzia Milito; Valentina Soccodato; Giulia Collalti; Alison Lanciarotta; Ilaria Bertozzi; Marcello Rattazzi; Riccardo Scarpa; Francesco Cinetto
Journal:  Vaccines (Basel)       Date:  2021-06-09

7. 

Authors:  Hans-Jürgen Laws; Ulrich Baumann; Christian Bogdan; Gerd Burchard; Maximilian Christopeit; Jane Hecht; Ulrich Heininger; Inken Hilgendorf; Winfried Kern; Kerstin Kling; Guido Kobbe; Wiebe Külper; Thomas Lehrnbecher; Roland Meisel; Arne Simon; Andrew Ullmann; Maike de Wit; Fred Zepp
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2020-05       Impact factor: 1.513

8.  Vaccination coverage among paediatric onco-haematological patients: an Italian cross-sectional study.

Authors:  Paola Giordano; Nicola Santoro; Pasquale Stefanizzi; Stefano Termite; Sara De Nitto; Francesco Paolo Bianchi; Paola Carmela Corallo; Giuseppe Lassandro; Silvio Tafuri
Journal:  Hum Vaccin Immunother       Date:  2020-08-26       Impact factor: 3.452

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.